3rd Department of Pediatrics, Aristotle University School of Medicine, Hippokration Hospital, Thessaloniki, Greece.
Pediatr Infect Dis J. 2011 Aug;30(8):707-10. doi: 10.1097/INF.0b013e31820d7ec4.
The outcome of patients with urinary tract infections caused by extended spectrum β-lactamases (ESBL)-producing bacteria (cases) was compared with that of matched controls with urinary tract infections caused by non-extended spectrum β-lactamases-producing isolates. Significantly, more case patients received inappropriate empiric therapy than controls. Nevertheless, clinical and microbiologic outcomes as well as formation of renal scars did not differ between the 2 groups.
产Extended-spectrum β-lactamases (ESBL)-的细菌引起的尿路感染患者（病例）的治疗结果与非产 Extended-spectrum β-lactamases 的细菌引起的尿路感染患者（对照组）的治疗结果进行了比较。值得注意的是，与对照组相比，更多的病例患者接受了不适当的经验性治疗。然而，两组之间的临床和微生物学治疗结果以及肾瘢痕的形成并无差异。
